| 2023 |
Paganini C, Carroll RS, Gramegna Tota C, Schelhaas AJ, Leone A, Duker AL, O'Connell DA, Coghlan RF, Johnstone B, Ferreira CR, Peressini S, Albertini R, Forlino A, Bonafé L, Campos-Xavier AB, Superti-Furga A, Zankl A, Rossi A, Bober MB. Identification of potential non-invasive biomarkers in diastrophic dysplasia. Bone. October 2023;175:116838. |
0 |
0 |
| 2004 |
Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. April 2004;19(4):614-622. |
30 |
18 |
| 2021 |
Costantini A, Alm JJ, Tonelli F, Valta H, Huber C, Tran AN, Daponte V, Kirova N, Kwon Y, Bae JY, Chung WY, Tan S, Sznajer Y, Nishimura G, Näreoja T, Warren AJ, Cormier‐Daire V, Kim O, Forlino A, Cho T, Mäkitie O. Novel RPL13 variants and variable clinical expressivity in a human ribosomopathy with spondyloepimetaphyseal dysplasia. J Bone Miner Res. February 2021;36(2):283-297. |
0 |
0 |
| 2022 |
Forlino A. Shedding light on bone morphogenetic protein (BMP) signaling modifiers to modulate fibrodysplasia ossificans progressiva severity. J Bone Miner Res. November 2022;37(11):2055-2057. |
0 |
0 |
| 2016 |
Forlino A, Marini JC. Osteogenesis imperfecta. Lancet. April 16, 2016;387(10028):1657-1671. |
43 |
42 |